Molecular Diagnostics - Cancer Genomics Flashcards
What type of disease is cancer classified as?
Cancer is a genetic disease: both inherited and somatic (acquired).
This classification highlights that cancer can arise from genetic mutations passed down through generations or acquired during an individual’s life.
How many ‘driver’ mutations can be present in cancer?
Up to 10-20 ‘driver’ mutations.
Driver mutations are genetic alterations that contribute to the development and progression of cancer.
What is the significance of sequencing genomes in cancer research?
Sequence genomes (cancer tissue and normal) to find genetic changes and suggest possible therapies.
This process helps identify specific mutations that may be targeted for treatment.
What are somatic mutations?
Somatic mutations are inherited throughout a lifetime.
These mutations occur in non-germline cells and are not inherited by offspring.
What are germline mutations?
Germline mutations are inherited cancer mutations.
These mutations are present in the reproductive cells and can be passed to the next generation.
What is a key factor that leads to cancer development?
Polymerase makes mistakes in key genes involved in cell proliferation.
Errors in DNA replication can lead to the accumulation of mutations that promote cancer.
What advantage do tumor cells gain from mutations?
Tumor cells gain a selective growth advantage.
This advantage allows cancer cells to proliferate more rapidly than normal cells.
True or False: The same type of cancer can have different mutations in different patients.
True.
Each cancer patient may have their own unique mutations, even if they have the same type of cancer.
What is the trend in targeted therapies for cancer?
There has been a huge increase in small molecule inhibitors that inhibit specific cancers.
These targeted therapies are designed to attack specific genetic mutations found in cancer cells.
What is The Cancer Genome Atlas (TCGA)?
A cancer sequencing project collecting tissues from 11,000 patients
TCGA provides genomic data for various cancers, facilitating research and treatment.
When did The Cancer Genome Atlas project start and complete?
Started in 2009 and completed in 2016
This timeline reflects the extensive research and data collection involved in the project.
How many patients’ tissues were collected for The Cancer Genome Atlas?
11,000 patients
This large sample size allows for a comprehensive analysis of cancer genomics.
What type of cancers were studied in The Cancer Genome Atlas?
Cancers included:
* Brain (Glioma, Glioblastoma)
* Breast
* Gastrointestinal (Colon, Rectal, Stomach)
* Gynaecologic (Ovarian, Cervical, Uterine)
* Head and Neck
* Hematologic (AML)
* Melanoma
* Lung
* Urologic (Kidney, Prostate)
These categories encompass a wide range of cancer types for comprehensive research.
Where is all TCGA data currently stored?
Genomic Data Commons
The GDC portal provides public access to genomic data for further research.
What is the European equivalent of The Cancer Genome Atlas?
COSMIC
COSMIC (Catalog of Somatic Mutations in Cancer) is a database of somatic mutations in cancer.
What type of data was primarily compared in The Cancer Genome Atlas?
Cancer biopsies and normal biopsies
This comparison helps identify genetic differences that may drive cancer.
What percentage of patients in TCGA were subjected to whole genome sequencing?
22%
This indicates a focused approach on a subset of patients for detailed genomic analysis.
True or False: The data from The Cancer Genome Atlas is freely available.
True
This accessibility supports global research initiatives in cancer biology.
What is the purpose of cancer genome sequencing?
To identify key mutations by comparing tumor DNA/RNA to normal DNA/RNA
This process helps in understanding the genetic variations specific to cancer.
What samples are typically collected for cancer genome sequencing?
Tumor biopsy and normal biopsy taken at the same time
This dual sampling allows for a direct comparison between cancerous and healthy cells.
Why is it important to differentiate between normal genetic variation and cancer mutations?
To accurately identify mutations that contribute to cancer development
Genetic variation can exist in everyone, making it crucial to distinguish between benign variations and those that indicate cancer.
What is one of the main analyses performed during cancer genome sequencing?
Sequencing and alignment to a reference genome
This step helps in identifying mutations by comparing sequenced data against a standard genome.